ERCC1 expression affects outcome in metastatic pancreatic carcinoma treated with FOLFIRINOX: A single institution analysis

INTRODUCTION: No clinically useful predictive factor has been yet identified for treatment of metastatic pancreatic cancer (mPC). It is noteworthy that FOLFIRINOX, despite its high toxicity, is effective only in some patients. We retrospectively analyzed expression of excision repair cross-complemen...

Descripción completa

Detalles Bibliográficos
Autores principales: Strippoli, Antonia, Rossi, Sabrina, Martini, Maurizio, Basso, Michele, D'Argento, Ettore, Schinzari, Giovanni, Barile, Rosalba, Cassano, Alessandra, Barone, Carlo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5085217/
https://www.ncbi.nlm.nih.gov/pubmed/27147577
http://dx.doi.org/10.18632/oncotarget.9063

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5085217/
https://www.ncbi.nlm.nih.gov/pubmed/27147577
http://dx.doi.org/10.18632/oncotarget.9063

Ejemplares similares